Max GaitaninHumanFirstUtilizing connected sensors to power diverse and equitable clinical trialsOur newest publication in Nature npj Digital Medicine outlines current evidence and a solution framework for diversity in research using…Oct 10, 2023Oct 10, 2023
Max GaitaninHumanFirstDigital endpoints widely adopted in pharmaceutical and biotech-sponsored clinical trialsOver 130 pharma and biotech organizations have relied on AI-powered digital biomarkers and sensor-derived clinical outcome assessments…Sep 28, 2023Sep 28, 2023